AI can support HPSR—but responsible adoption needs safeguards: governance, equity, and data sovereignty. Key point: accelerate steps, yes; replace rigorous methods, no.
More on our website: https://t.co/9E0lzcucAi
#HPSR#PublicHealth#AI#Evidence#Epistemonikos
The latest issue of our newsletter highlights our Journal of Clinical Epidemiology article on Sustainable Knowledge as a framework to improve evidence synthesis—quality, efficiency, and minimal redundancy.
Read the newsletter 👇
https://t.co/kSTOEUaipz
The latest issue of our newsletter highlights our Journal of Clinical Epidemiology article on Sustainable Knowledge as a framework to improve evidence synthesis—quality, efficiency, and minimal redundancy.
Read the newsletter 👇
https://t.co/kSTOEUaipz
En salud sobran papeles y faltan certezas. Con @Epistemonikos, Gabriel Rada acerca conocimiento confiable a quienes deciden. 🎧 #Biodots
https://t.co/4Pxg0qe43z
https://t.co/aEZwTbpW9s
@Marco_Care_AI
👋 Farewell to the Number Needed to Treat after 35 years of service.
🙏🕊️🎖️
Murad et al. argue it’s time to retire the NNT and embrace the Risk Difference.
The NNT is dead, long live the RD!
https://t.co/cEIc1IAvSI
The #GRADE evidence to decision (EtD) framework provides invaluable guidance in moving from evidence to recommendations. There are a number of variations for specific areas. This article explains EtD frameworks for #HealthSystem and policy decisions.
https://t.co/iYQgichY9A
I would like to express my deep gratitude to three reviewers of the #BMJ Core #GRADE papers, Sheri Keitz, Ariel Izcovich, and Mark Helfand whose careful, meticulous, and insightful reviews had a huge positive impact on the series.
Delivering up-to-date, high-quality evidence is feasible during emergencies: PAHO living SR of 305 COVID-19 therapeutics
https://t.co/dx2xYu2OAA
Collaboration @pahowho + @epistemonikos
led by @IzcovichA
Repository
https://t.co/oLHnYRKD7S
Result's website
https://t.co/hCUkpgf79w
Breakthrough for #EBM! #GRADE, leading resource for certainty of evidence and evidence to recommendations now too complex, disorganized. Solution in 7 papers on GRADE essentials “Core GRADE” in #BMJ. This week, introduction to series summarizes content.
https://t.co/qLkgB9NEWN
Big news for #EBM! Just out in #BMJ, ROBUST-RCT, pristinely developed, innovative, simple, user-friendly instrument for risk of bias assessment in #RCTs far superior to anything before, will become standard outside of Cochrane and in #Cochrane if they let folks use it.
https://t.co/iEROPshcRW
Systematic review of VTE treatment: Shorter anticoagulation (3-6 m) better for all types of VTE. For secondary prevention of unprovoked VTE or VTE provoked by chronic risk factors, indefinite treatment is more beneficial.
https://t.co/vipPJnei1A
congratas to @MadisonYZhang et al
#AireFresco | Gabriel Rada: "Si a una persona un experto le dice A y otro Z, dice que hay controversia y se olvida (...) Es vital que el mundo científico actúe como bloque y que tenga la información clara y a tiempo"
▶️En vivo https://t.co/gX74R82LfS App, YouTube, Instagram y dial
Congratulations to the Mexican Society of Nutrition and Endocrinology on their new #obesity clinical practice guidelines! No doubt this guideline will become a new benchmark for obesity care in Mexico! @epistemonikos@Obesidades_mx
https://t.co/tHVJjpYRYQ
Still digesting the whirlwind that was #GES2024…. But one thing is certain, it stayed true to its mission of bringing the evidence community together, I worked closely with colleagues from @cochranecollab@CampbellReviews@ebase_africa & others and it brought so much joy! #EBHC
We launched the #HTAi2024 conference with an exciting workshop on the integration of the LE model into HTA led by the LE-IHD team with the collaboration of researchers from @iacs_aragon and @bioef 🤝A big thank you to all the fantastic participants. Stay tuned!